COVID: Heartburn Drug Being Studied As Treatment

Photo: CDC

App users, tap here to watch video.

NEW YORK – Multiple clinical trials are underway to find a treatment for Coronavirus, including one involving a popular heartburn medication.











Researchers in New York City are studying the active ingredient in Pepcid, called Famotidine.

It’s because of something doctors observed in China.







“Patients who were sick with COVID but were taking famotidine had a, had a better outcome,” said Dr. Kevin Tracey. “There are many examples in the history of medicine where a drug that was designed for one purpose turns out to have an effect in another disease.”

Although, Dr. Tracey warned don’t rush out to buy heartburn medicine, the patients in the study are in the hospital, getting mega-doses intravenously and it’s not clear that it will work.





















 

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.